Oculus Innovative Sciences Inc. (NASDAQ:OCLS) shares were down 4.4% during trading on Thursday . The stock traded as low as $4.26 and last traded at $4.35, with a volume of 90,406 shares traded. The stock had previously closed at $4.55.

Separately, Maxim Group reiterated a “buy” rating and issued a $7.00 price target on shares of Oculus Innovative Sciences in a research note on Thursday, August 11th.

The company has a 50-day moving average of $4.13 and a 200-day moving average of $4.67. The firm’s market cap is $18.02 million.

Oculus Innovative Sciences (NASDAQ:OCLS) last announced its quarterly earnings data on Thursday, July 28th. The company reported ($0.61) earnings per share (EPS) for the quarter. On average, equities analysts forecast that Oculus Innovative Sciences Inc. will post ($2.04) EPS for the current year.

Oculus Innovative Sciences, Inc is a specialty pharmaceutical company, which focuses on identifying, developing and commercializing therapies to manage the lives of patients with dermatologic diseases or conditions. The Company’s products treat certain topical skin diseases, including acne, atopic dermatitis, scarring, infections, itch, pain and inflammatory responses.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.